PEGZILARGINASE-NBLN

PEGZILARGINASE-NBLN was reported 31 times

PEGZILARGINASE-NBLN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ARGININE LEVEL DECREASED 2 0.6667
1 HYPERAMMONAEMIC CRISIS 3 0.0280
2 WRONG DEVICE USED 2 0.0030
3 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 2 0.0030
4 AMINO ACID LEVEL INCREASED 2 0.0027
5 HYPERAMMONAEMIA 12 0.0024
6 RED BLOOD CELL ABNORMALITY 2 0.0021
7 TRANSAMINASES ABNORMAL 1 0.0017
8 AMMONIA INCREASED 8 0.0016
9 HYPERAMMONAEMIC ENCEPHALOPATHY 2 0.0011
10 KETOSIS 1 0.0009
11 APHTHOUS ULCER 2 0.0003
12 HYPOTONIA 2 0.0002
13 FEEDING DISORDER 2 0.0001
14 TRANSAMINASES INCREASED 2 0.0001
15 GASTROENTERITIS 1 0.0001
16 LIVER FUNCTION TEST INCREASED 1 0.0000
17 COMA 2 0.0000
18 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
19 HEPATIC ENZYME INCREASED 2 0.0000
20 HYPERGLYCAEMIA 1 0.0000
21 DISORIENTATION 1 0.0000
22 DECREASED APPETITE 5 0.0000
23 SOMNOLENCE 4 0.0000
24 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
25 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
26 PERIPHERAL SWELLING 2 0.0000
27 PYREXIA 4 0.0000
28 VOMITING 5 0.0000
29 ILLNESS 1 0.0000
30 WEIGHT INCREASED 2 0.0000
31 SEIZURE 1 0.0000
32 INJECTION SITE ERYTHEMA 1 0.0000
33 CONDITION AGGRAVATED 2 0.0000
34 CONFUSIONAL STATE 1 0.0000
35 ASTHENIA 2 0.0000
36 ABDOMINAL PAIN UPPER 1 0.0000
37 ABDOMINAL PAIN 1 0.0000
38 NAUSEA 2 0.0000
39 PAIN 1 0.0000
40 FATIGUE 1 0.0000